刘艳秋 职务: 副教授 专业: 整合医学 Education/Working Experience

2001.9-2006.6, Shenyang Pharmaceutical University, Ph.D

2006.7-2013.11, Dalian Institute of Chemical Physics, Chinese Academy of Science, associate research fellow

2013.12-present , Dalian Medical University, associate professor Research Projects/Grants

National Natural Science Foundation of China (81473545); 2015/01-2018/12

Admission Plan/Requirements

1 person

Council member of the board of

Specialty Committee of Gerontology of World Federation of Chinese Medicine Societies

2015.12-2019.12

1． Yan-Qiu Liu, Li-Bin Zhan, Tie-Gang Liu, Meng-Chun Cheng, Xiao-Yan Liu, Hong-Bin Xiao. Inhibitory effect of Ecliptae herba extract and its component wedelolactone on pre-osteoclastic proliferation and differentiation. J Ethnopharmacol. 2014, 157: 206-211. 2.998 2． Yan-Qiu Liu, Qian-Xu Yang, Meng-Chun Cheng, Hong-Bin Xiao, Synergistic inhibitory effect of Icariside II with Icaritin from Herba Epimedii on pre-osteoclastic RAW264.7 cell growth. Phytomedicine, 2014, 219 (12):1633-1637. 3.126 3． Yan-Qiu Liu, Xiao-Fei Han, Tie-Gang Liu, Meng-Chun Cheng, Hong-Bin Xiao. A cell-based model of bone remodeling for identifying activity of icarrin in the treatment of osteoporosis. Biotechnol Lett. 2015, 37 (1): 219-226. 1.591 4． Liu X, Liu Y, Cheng M, Xiao H. Metabolomic Responses of Human Hepatocytes to Emodin, Aristolochic Acid, and Triptolide: Chemicals Purified from Traditional Chinese Medicines. J Biochem Mol Toxicol. 2015, 29(11):533-43